Phillip Gambel

Array ( [id] => 10592860 [patent_doc_number] => RE045976 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2016-04-19 [patent_title] => 'Methods of inhibiting the action of TNF for neurological conditions by administering etanercept intrathecally' [patent_app_type] => reissue [patent_app_number] => 12/344437 [patent_app_country] => US [patent_app_date] => 2008-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4633 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12344437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501666 [patent_doc_number] => 20090162354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'INHIBITORS OF PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND/OR VASCULAR LEAKAGE' [patent_app_type] => utility [patent_app_number] => 12/341177 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14573 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162354.pdf [firstpage_image] =>[orig_patent_app_number] => 12341177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514864 [patent_doc_number] => 20090215171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'PELCAM-1-related molecules compositions kit of parts and associated methods of use' [patent_app_type] => utility [patent_app_number] => 12/317096 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7111 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215171.pdf [firstpage_image] =>[orig_patent_app_number] => 12317096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4567951 [patent_doc_number] => 07829092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Recombinant anti-VLA4 antibody molecules' [patent_app_type] => utility [patent_app_number] => 12/338570 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19779 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829092.pdf [firstpage_image] =>[orig_patent_app_number] => 12338570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477802 [patent_doc_number] => 20100285072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Method for Producing Dendritic Cells' [patent_app_type] => utility [patent_app_number] => 12/747759 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17492 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285072.pdf [firstpage_image] =>[orig_patent_app_number] => 12747759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380247 [patent_doc_number] => 20090192086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'IDENTIFICATION OF A NOVEL BHD GENE' [patent_app_type] => utility [patent_app_number] => 12/334361 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29477 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192086.pdf [firstpage_image] =>[orig_patent_app_number] => 12334361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508025 [patent_doc_number] => 20090081232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/329428 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5309 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081232.pdf [firstpage_image] =>[orig_patent_app_number] => 12329428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095327 [patent_doc_number] => 20110002934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'USES OF ANTI-CD40 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/741161 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26907 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002934.pdf [firstpage_image] =>[orig_patent_app_number] => 12741161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270989 [patent_doc_number] => 20090074765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'INHIBITORS OF PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND/OR VASCULAR LEAKAGE' [patent_app_type] => utility [patent_app_number] => 12/265046 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14575 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074765.pdf [firstpage_image] =>[orig_patent_app_number] => 12265046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545959 [patent_doc_number] => 20090155836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'METHODS FOR TREATING HIV INFECTED SUBJECTS' [patent_app_type] => utility [patent_app_number] => 12/255861 [patent_app_country] => US [patent_app_date] => 2008-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 40059 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155836.pdf [firstpage_image] =>[orig_patent_app_number] => 12255861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615960 [patent_doc_number] => 20100310579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'METHOD FOR INHIBITING ANGIOGENESIS OR FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/740566 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6116 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310579.pdf [firstpage_image] =>[orig_patent_app_number] => 12740566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284461 [patent_doc_number] => 20090098136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'USE OF TNF RECEPTOR ANTAGONISTS FOR TREATING DRY EYE' [patent_app_type] => utility [patent_app_number] => 12/251699 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2882 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098136.pdf [firstpage_image] =>[orig_patent_app_number] => 12251699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4559049 [patent_doc_number] => 07838489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Methods of treating rheumatoid arthritis with p75 TNF-alpha receptor and methotrexate' [patent_app_type] => utility [patent_app_number] => 12/287340 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 26 [patent_no_of_words] => 17773 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838489.pdf [firstpage_image] =>[orig_patent_app_number] => 12287340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409568 [patent_doc_number] => 20090123466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'ANTI-CD40 MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/246325 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21869 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123466.pdf [firstpage_image] =>[orig_patent_app_number] => 12246325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 216800 [patent_doc_number] => 07611708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies' [patent_app_type] => utility [patent_app_number] => 12/246029 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19048 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611708.pdf [firstpage_image] =>[orig_patent_app_number] => 12246029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278583 [patent_doc_number] => 20090130715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Antibodies to CD40' [patent_app_type] => utility [patent_app_number] => 12/284605 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 41925 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130715.pdf [firstpage_image] =>[orig_patent_app_number] => 12284605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354693 [patent_doc_number] => 20090186037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'METHODS FOR INHIBITING AN IMMUNE RESPONSE BY BLOCKING THE GP39/CD40 AND CTLA4/CD28/B7 PATHWAYS AND COMPOSITIONS FOR USE THEREWITH' [patent_app_type] => utility [patent_app_number] => 12/207997 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10208 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186037.pdf [firstpage_image] =>[orig_patent_app_number] => 12207997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272110 [patent_doc_number] => 20090075886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Dendritic cell stimulatory factor' [patent_app_type] => utility [patent_app_number] => 12/187575 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7358 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075886.pdf [firstpage_image] =>[orig_patent_app_number] => 12187575 [rel_patent_id] =>[rel_patent_doc_number] =>)